查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1529823

精神科数位生物标记市场规模、份额和趋势分析报告：按类型、医疗实践、最终用途、地区和细分趋势：2024-2030

Psychiatric Digital Biomarkers Market Size, Share & Trends Analysis Report By Type, By Clinical Practice, By End Use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

精神科数位生物标记市场趋势

预计 2023 年全球精神科数位生物标记市场规模为 5.219 亿美元，2024 年至 2030 年复合年增长率预估为 23.9%。精神疾病盛行率的增加、数位健康技术的进步以及对个人化医疗的需求不断增长正在推动市场发展。穿戴式装置和行动医疗应用程式在精神健康保健领域的日益普及也促进了市场的成长。 2024 年 4 月，Sensors 发表了一篇关于数位表型分析对神经系统疾病影响的综述，展示了透过远端医疗和感测器技术改善临床试验并支持早期检测和监测的潜力。

忧郁症、焦虑症、躁郁症和思觉失调症等精神疾病影响全世界数百万人。根据美国心理健康公司的数据，2023 年，12 至 17 岁的青少年中有 20.17% 经历过严重忧郁症，15% 患有严重残疾，影响了他们的日常生活。这种日益增加的盛行率促使需要更有效的工具来监测和管理心理健康状况，导致人们对精神病数位生物标记物的兴趣增加。 2022 年 7 月，普适和行动运算发表的研究表明，忧郁症患者和非忧郁症患者的情绪和数字标记（例如睡眠和电话使用）存在显着差异。也证实，这些数位生物标记物单独或与情绪评估相结合，可以准确预测忧郁症状态。

数位健康科技的进步将彻底改变心理健康领域。人工智慧 (AI)、机器学习和资料分析等技术创新促进了先进数位生物标记的开发，为个人心理健康状况提供了宝贵的见解。人工智慧驱动的演算法分析来自智慧型手机感测器的资料，以检测行为模式的变化，这些变化表明心理健康危机的早期征兆。

2023 年 11 月，《精神病学前沿》上的报导强调了数位生物标记在预测和管理情绪障碍方面的潜力、智慧型手机资料如何监测忧郁症和治疗反应，以及穿戴式装置如何监测现实世界中的忧郁症和治疗反应。

随着医疗保健提供者寻求根据患者个别需求量身定制治疗计划，精神健康保健中对个人化医疗的需求不断增长。精神科数位生物标记透过提供有关患者症状和治疗反应的客观资料，在实现个人化介入方面发挥重要作用。穿戴式装置和行动医疗应用程式的日益普及将透过在传统临床环境之外实现持续的患者监测来进一步加速这一趋势。 2022 年 3 月，DTU 健康科技的研究人员开发了一种使用语音分析来识别个别双相情感障碍并监测患者情绪变化的方法，发现个人化模型提供的结果是最准确的。

全球精神科数位生物标记市场报告细分

该报告预测了全球、区域和国家层面的收益成长，并对 2018 年至 2030 年各子区隔的最新行业趋势进行了分析。在这项研究中，Grand View Research, Inc. 根据类型、临床实践、最终用途和地区对全球精神科数位生物标记市场报告进行了细分。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章 精神科数位生物标记市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/补充市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 精神科数位生物标记市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第 4 章 精神科数位生物标记市场：按类型估计和趋势分析

  • 细分仪表板
  • 全球精神科数位生物标记市场类型变化分析
  • 2018-2030 年全球精神科数位生物标记市场规模与趋势分析（按类型）
  • 穿戴式的
  • 基于行动的应用程式
  • 感应器
  • 其他的

第五章精神科数位生物标记市场：临床实践的估计和趋势分析

  • 细分仪表板
  • 全球精神科数位生物标记市场的临床实践变化分析
  • 2018-2030 年全球精神科数位生物标记市场规模与趋势分析（按临床实务）
  • 精神科数位生物标记诊断
  • 精神科数位生物标记监测
  • 使用数位生物标记预测和预后精神障碍
  • 其他（安全性、动态/反应、敏感性）

第六章 精神科数位生物标记市场：最终用途的估计与趋势分析

  • 细分仪表板
  • 全球精神科数位生物标记市场的最终用途变化分析
  • 2018-2030 年全球精神科数位生物标记市场规模与趋势分析（依最终用途）
  • 医疗公司
  • 医疗提供者
  • 付款人
  • 其他（病人、看护者）

第 7 章 精神科数位生物标记市场：区域、估计与趋势分析

  • 2023 年及 2030 年按地区分類的市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模、预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争格局

  • 公司/竞争对手分类
  • 策略规划
  • 2023 年企业市场分析
  • 公司简介/上市公司
    • Koneksa
    • Biogen Inc.
    • Empatica Inc.
    • Vivo Sense
    • IXICO plc
    • Huma
    • Sonde Health, Inc.
    • Clario
Product Code: GVR-4-68040-367-6

Psychiatric Digital Biomarkers Market Trends

The global psychiatric digital biomarkers market was estimated at USD 521.9 million in 2023 and is projected to grow at a CAGR of 23.9% from 2024 to 2030. The increasing prevalence of mental health disorders, advancements in digital health technologies and growing demand for personalized medicine drive the market. Rising adoption of wearable devices and mobile health apps in mental healthcare contribute to the market growth. In April 2024, Sensors published a review on digital phenotyping's impact on neurological diseases, showing its potential to refine clinical trials and aid in early detection and monitoring through telemedicine and sensor technologies.

The global burden of mental health disorders is on the rise, with conditions such as depression, anxiety, bipolar disorder, and schizophrenia affecting millions of people worldwide. In 2023, Mental Health America, Inc. found that 20.17% of youths aged 12-17 had encountered a major depressive episode, with 15% suffering severe impairment affecting daily activities. This increasing prevalence is driving the need for more effective tools to monitor and manage mental health conditions, leading to a growing interest in psychiatric digital biomarkers. In July 2022, Pervasive and Mobile Computing published findings showing significant differences in mood and digital markers (such as sleep and phone usage) between depressed and non-depressed individuals. It also confirmed that depression status could be accurately predicted using these digital biomarkers alone or combined with mood ratings.

Technological advancements in digital health technologies revolutionize the field of mental healthcare. Innovations such as artificial intelligence (AI), machine learning, and data analytics enable the development of sophisticated digital biomarkers that provide valuable insights into an individual's mental health status. AI-powered algorithms analyze data from smartphone sensors to detect changes in behavior patterns that indicate early signs of a mental health crisis.

In November 2023, an article in Frontiers in Psychiatry highlighted the potential of digital biomarkers in predicting and managing mood disorders, noting how smartphone data can monitor depression and treatment responses, wearable devices can track mood disorders more accurately in real-world settings, and AI advancements are opening up new diagnostic and therapeutic avenues.

There is a growing demand for personalized medicine in mental healthcare, as healthcare providers seek to tailor treatment plans to individual patients' needs. Psychiatric digital biomarkers play a crucial role in enabling personalized interventions by providing objective data on patients' symptoms and treatment responses. The increasing adoption of wearable devices and mobile health apps further fuels this trend, allowing for continuous monitoring of patients outside traditional clinical settings. In March 2022, DTU Health Tech researchers developed a method using voice analysis to identify bipolar disorder in individuals and monitor mood changes in patients, with personalized models providing the most accurate results.

Global Psychiatric Digital Biomarkers Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global psychiatric digital biomarkers market report based on type, clinical practice, end use, and region.

  • Type Outlook (Revenue, USD Million, 2018 - 2030)
  • Wearable
  • Mobile based Applications
  • Sensors
  • Others
  • Clinical Practice Outlook (Revenue, USD Million, 2018 - 2030)
  • Diagnostic Psychiatric Digital Biomarkers
  • Monitoring Psychiatric Digital Biomarkers
  • Predictive and Prognostic Psychiatric Digital Biomarkers
  • Other's (Safety, Pharmacodynamics/ Response, Susceptibility)
  • End Use Outlook (Revenue, USD Million, 2018 - 2030)
  • Healthcare companies
  • Healthcare Providers
  • Payers
  • Others (Patient, caregivers)
  • Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America

U.S.

Canada

Mexico

  • Europe

Germany

UK

France

Italy

Spain

Denmark

Sweden

Norway

  • Asia Pacific

China

Japan

India

South Korea

Australia

Thailand

  • Latin America

Brazil

Argentina

  • MEA

South Africa

Saudi Arabia

UAE

Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Type
    • 1.2.2. Clinical Practice
    • 1.2.3. End Use
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Insights Landscape

Chapter 3. Psychiatric Digital Biomarkers Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of mental health disorders,
      • 3.2.1.2. Advancements in digital health technologies
      • 3.2.1.3. Growing demand for personalized medicine
      • 3.2.1.4. Rising adoption of wearable devices and mobile health apps
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Regulatory hurdles
  • 3.3. Psychiatric Digital Biomarkers Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's Five Forces
    • 3.3.2. PESTEL Analysis

Chapter 4. Psychiatric Digital Biomarkers Market: Type Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Psychiatric Digital Biomarkers Market Type Movement Analysis
  • 4.3. Global Psychiatric Digital Biomarkers Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Wearable
    • 4.4.1. Wearable market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.5. Mobile based Applications
    • 4.5.1. Mobile based applications market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.6. Sensors
    • 4.6.1. Sensors market estimates and forecasts 2018 to 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Psychiatric Digital Biomarkers Market: Clinical Practice Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Psychiatric Digital Biomarkers Market Clinical Practice Movement Analysis
  • 5.3. Global Psychiatric Digital Biomarkers Market Size & Trend Analysis, by Clinical Practice, 2018 to 2030 (USD Million)
  • 5.4. Diagnostic Psychiatric Digital Biomarkers
    • 5.4.1. Diagnostic psychiatric digital biomarkers market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5. Monitoring Psychiatric Digital Biomarkers
    • 5.5.1. Monitoring psychiatric digital biomarkers market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.6. Predictive and Prognostic Psychiatric Digital Biomarkers
    • 5.6.1. Predictive and prognostic psychiatric digital biomarkers market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.7. Other's (Safety, Pharmacodynamics/ Response, Susceptibility)
    • 5.7.1. Other's (safety, pharmacodynamics/ response, susceptibility) market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Psychiatric Digital Biomarkers Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global Psychiatric Digital Biomarkers Market End Use Movement Analysis
  • 6.3. Global Psychiatric Digital Biomarkers Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 6.4. Healthcare Companies
    • 6.4.1. Healthcare companies market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Healthcare Providers
    • 6.5.1. Healthcare providers market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. Payers
    • 6.6.1. Payers market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.7. Others (Patient, Caregivers)
    • 6.7.1. Others (patient, caregivers) market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Psychiatric Digital Biomarkers Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.4. North America
    • 7.4.1. U.S.
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.2. Canada
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.4.3. Mexico
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.5. Europe
    • 7.5.1. UK
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Germany
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.3. France
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.4. Italy
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.5. Spain
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.6. Norway
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.7. Sweden
      • 7.5.7.1. Key country dynamics
      • 7.5.7.2. Regulatory framework
      • 7.5.7.3. Competitive scenario
      • 7.5.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.8. Denmark
      • 7.5.8.1. Key country dynamics
      • 7.5.8.2. Regulatory framework
      • 7.5.8.3. Competitive scenario
      • 7.5.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Asia Pacific
    • 7.6.1. Japan
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. China
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. India
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Australia
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. South Korea
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Thailand
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Latin America
    • 7.7.1. Brazil
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. Argentina
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. MEA
    • 7.8.1. South Africa
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Saudi Arabia
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3. UAE
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.4. Kuwait
      • 7.8.4.1. Key country dynamics
      • 7.8.4.2. Regulatory framework
      • 7.8.4.3. Competitive scenario
      • 7.8.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Market Position Analysis, 2023
  • 8.4. Company Profiles/Listing
    • 8.4.1. Koneksa
      • 8.4.1.1. Company overview
      • 8.4.1.2. Financial performance
      • 8.4.1.3. Type benchmarking
      • 8.4.1.4. Strategic initiatives
    • 8.4.2. Biogen Inc.
      • 8.4.2.1. Company overview
      • 8.4.2.2. Financial performance
      • 8.4.2.3. Type benchmarking
      • 8.4.2.4. Strategic initiatives
    • 8.4.3. Empatica Inc.
      • 8.4.3.1. Company overview
      • 8.4.3.2. Financial performance
      • 8.4.3.3. Type benchmarking
      • 8.4.3.4. Strategic initiatives
    • 8.4.4. Vivo Sense
      • 8.4.4.1. Company overview
      • 8.4.4.2. Financial performance
      • 8.4.4.3. Type benchmarking
      • 8.4.4.4. Strategic initiatives
    • 8.4.5. IXICO plc
      • 8.4.5.1. Company overview
      • 8.4.5.2. Financial performance
      • 8.4.5.3. Type benchmarking
      • 8.4.5.4. Strategic initiatives
    • 8.4.6. Huma
      • 8.4.6.1. Company overview
      • 8.4.6.2. Financial performance
      • 8.4.6.3. Type benchmarking
      • 8.4.6.4. Strategic initiatives
    • 8.4.7. Sonde Health, Inc.
      • 8.4.7.1. Company overview
      • 8.4.7.2. Financial performance
      • 8.4.7.3. Type benchmarking
      • 8.4.7.4. Strategic initiatives
    • 8.4.8. Clario
      • 8.4.8.1. Company overview
      • 8.4.8.2. Financial performance
      • 8.4.8.3. Type benchmarking
      • 8.4.8.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 Global psychiatric digital biomarkers market, by region, 2018 - 2030 (USD Million)
  • Table 3 Global psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 4 Global psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 5 Global psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 North America psychiatric digital biomarkers market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 8 North America psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 9 North America psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 10 U.S. psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 11 U.S. psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 12 U.S. psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 13 Canada psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 14 Canada psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 15 Canada psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Mexico psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 17 Mexico psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 18 Mexico psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 Europe psychiatric digital biomarkers market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 21 Europe psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 22 Europe psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 23 Germany psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 24 Germany psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 25 Germany psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 26 UK psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 27 UK psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 28 UK psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 29 France psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 30 France psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 31 France psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 32 Italy psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 33 Italy psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 34 Italy psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 35 Spain psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 36 Spain psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 37 Spain psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 38 Denmark psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 39 Denmark psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 40 Denmark psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 41 Sweden psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 42 Sweden psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million
  • Table 43 Sweden psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million
  • Table 44 Norway psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 45 Norway psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million
  • Table 46 Norway psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million
  • Table 47 Asia Pacific psychiatric digital biomarkers market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million
  • Table 50 Asia Pacific psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million
  • Table 51 China psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 52 China psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 53 China psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 54 Japan psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 55 Japan psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 56 Japan psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 57 India psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 58 India psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 59 India psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 60 South Korea psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 61 South Korea psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 62 South Korea psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 63 Australia psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 64 Australia psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 65 Australia psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Thailand psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 67 Thailand psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 68 Thailand psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Latin America psychiatric digital biomarkers market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 71 Latin America psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 72 Latin America psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 73 Brazil psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 74 Brazil psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 75 Brazil psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 76 Argentina psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 77 Argentina psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 78 Argentina psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 MEA psychiatric digital biomarkers market, by country, 2018 - 2030 (USD Million)
  • Table 80 MEA psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 81 MEA psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 82 MEA psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 83 South Africa psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 84 South Africa psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 85 South Africa psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 89 UAE psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 90 UAE psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 91 UAE psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)
  • Table 92 Kuwait psychiatric digital biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 93 Kuwait psychiatric digital biomarkers market, by clinical practice, 2018 - 2030 (USD Million)
  • Table 94 Kuwait psychiatric digital biomarkers market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 Psychiatric digital biomarkers market: Market outlook
  • Fig. 5 Psychiatric digital biomarkers market: Segment outlook
  • Fig. 6 Psychiatric digital biomarkers market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 Psychiatric digital biomarkers market driver impact
  • Fig. 9 Psychiatric digital biomarkers market restraint impact
  • Fig. 10 Psychiatric digital biomarkers market: Type outlook and key takeaways
  • Fig. 11 Psychiatric digital biomarkers market: Type movement analysis
  • Fig. 12 Wearable market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 13 Mobile based applications market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 14 Sensors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 15 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 16 Psychiatric digital biomarkers market: Clinical Practice outlook and key takeaways
  • Fig. 17 Psychiatric digital biomarkers market: Clinical Practice movement analysis
  • Fig. 18 Diagnostic psychiatric digital biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 19 Monitoring psychiatric digital biomarkers market estimates and forecast, 2018 - 2030 (USD Million
  • Fig. 20 Predictive and prognostic psychiatric digital biomarkers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 21 Other's (safety, pharmacodynamics/ response, susceptibility) market estimates and forecast, 2018 - 2030 (USD Million
  • Fig. 22 Psychiatric digital biomarkers market: End Use outlook and key takeaways
  • Fig. 23 Psychiatric digital biomarkers market: End Use movement analysis
  • Fig. 24 Healthcare companies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Healthcare providers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Payers market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 27 Others market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 28 Global psychiatric digital biomarkers market: Regional outlook and key takeaways
  • Fig. 29 Global psychiatric digital biomarkers market: Regional movement analysis
  • Fig. 30 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Middle East and Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)